Pharmaceutical Quality (Industry)
1.0.0 - STU1 International flag

Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions

Example Bundle: Example: Bundle – Stability, product

Language: en

Profile: Bundle – Drug Stability PQ

Bundle bundle-drug-stability-pq-ex1-prod of type collection


Entry 1 - fullUrl = http://example.com/SubstanceDefinition/substance-drug-pq-ex1

Resource Substance:

Language: en

Profile: Substance - Drug PQ

Medication Manufacturing Batch

Extension - Batch Release Date PQ: 2019-09-08

Extension - Batch Retest Date PQ: 2022-09-08

Extension - Actual Yield PQ: 4.8 kg

identifier: CAT1

instance: false

Codes

-Concept
*Substance

Entry 2 - fullUrl = http://example.com/SpecimenDefinition/specimendefinition-drug-pq-ex1

Resource SpecimenDefinition:

Language: en

Profile: SpecimenDefinition - Drug PQ

status: Active

typeTested

preference: Preferred

Handlings

-Instruction
*

25°C/60% RH


Entry 3 - fullUrl = http://example.com/Substance/substance-drug-pq-ex1

Resource Substance:

Language: en

Profile: Substance - Drug PQ

Medication Manufacturing Batch

Extension - Batch Release Date PQ: 2019-09-08

Extension - Batch Retest Date PQ: 2022-09-08

Extension - Actual Yield PQ: 4.8 kg

identifier: CAT1

instance: false

Codes

-Concept
*Substance

Entry 4 - fullUrl = http://example.com/Specimen/specimen-drug-pq-ex1

Resource Specimen:

Language: en

Profile: Specimen - Drug PQ

Collections

-Collected[x]
*2020-12-01

processing

description: No storage

processing

description: 25°C/60% RH


Entry 5 - fullUrl = http://example.com/PlanDefinition/plandefinition-drug-pq-ex5-stability-study-protocol

Resource PlanDefinition:

Metadata
Title Stability Monitoring Program
Subject Type MedicinalProductDefinition: identifier = http://example.org/identifiers/product#PROD-12345; combinedPharmaceuticalDoseForm = Tablet; route = Oral use
Description

Narrative description of Stability Study

Type Stability Study Protocol
PlanDefinition Action
Title Stability Test Protocol for Long-term and Accelerated Storage of Stelbat Tablets, 20 mg
PlanDefinition Sub-Action (Parent Action Title: Stability Test Protocol for Long-term and Accelerated Storage of Stelbat Tablets, 20 mg)
Title Long-Term
Description

25°C/60% RH

PlanDefinition Sub-Action (Parent Action Title: Long-Term)
Title Initial
Timing Once
PlanDefinition Sub-Action (Parent Action Title: Initial)
Title XYZ
Definition http://example-server.com/fhir/ActivityDefinition/4bfe1ee8-91ed-5c1b-3045-c749bb9d1d90
Generated using version 0.5.4 of the sample-content-ig Liquid templates

Entry 6 - fullUrl = http://example.com/ActivityDefinition/activitydefinition-test-drug-pq-ex1

Resource ActivityDefinition:

Metadata
Title Example of ActivityDefinition - Test for test set: Long-term - 25°C/60% RH - XYZ.
Generated using version 0.5.4 of the sample-content-ig Liquid templates

Entry 7 - fullUrl = http://example.com/ObservationDefinition/accelerated40X

Resource ObservationDefinition:

status: Active

code: Battery of tests 'X' at 40°C/75% RH


Entry 8 - fullUrl = http://example.com/DiagnosticReport/diagnosticreport-analysis-drug-pq-stability-prod

Resource DiagnosticReport:

Stability Study Report - 18 months

When For2020-12
Performer Organization AAA Molybdenum Products, Inc.
Identifier https://eudract.europa.eu/example/identifier/ABC1234

Report Details

CodeValueFlagsWhen For
Test Components - Long-term 25C etc - Initial (XYZ)Final2023-01-01 12:00:00+0000

The samples have been assessed for initial period; no shelf life determined.


Entry 9 - fullUrl = http://example.com/Observation/observation-test-result-longterm25c-initial-1

Resource Observation:

Triggered by: Example of ActivityDefinition - Test for test set: Long-term - 25°C/60% RH - XYZ.

status: Final

code: Test Components - Long-term 25C etc - Initial (XYZ)

subject: Medication

effective: 2023-01-01 12:00:00+0000

performer: Organization AAA Molybdenum Products, Inc.

specimen: Specimen

hasMember:


Entry 10 - fullUrl = http://example.com/Organization/organization-drug-pq-ex1

Resource Organization:

Language: en

Profile: Organization - Drug PQ

identifier: FDA Establishment Identifier/3003040516

active: true

type: Drug Substance Manufacture

name: AAA Molybdenum Products, Inc.

Contacts

-Address
*7233 W 116th Pl Ste C Broomfield Colorado 80020 USA

Entry 11 - fullUrl = http://example.com/Organization/organization-drug-pq-ex1

Resource Organization:

Language: en

Profile: Organization - Drug PQ

identifier: FDA Establishment Identifier/3003040516

active: true

type: Drug Substance Manufacture

name: AAA Molybdenum Products, Inc.

Contacts

-Address
*7233 W 116th Pl Ste C Broomfield Colorado 80020 USA

Entry 12 - fullUrl = http://example.com/Organization/organization-drug-pq-ex1

Resource Organization:

Language: en

Profile: Organization - Drug PQ

identifier: FDA Establishment Identifier/3003040516

active: true

type: Drug Substance Manufacture

name: AAA Molybdenum Products, Inc.

Contacts

-Address
*7233 W 116th Pl Ste C Broomfield Colorado 80020 USA